BCL2 and B-cell chronic lymphocytic leukemia: In contrast, pro-caspase 7induction resulted in cell death but only in two of five cell lines tested(Li et al., 2001).Overexpression of B-Cell CLL/Lymphoma 2 (BCL-2) pro-apoptotic family memberssuch as BCL2 Antagonist/Killer 1 (BAK) and BCL2 Associated X (BAX) alsodemonstrated effective antitumor capacity through apoptosis induction (Table S3) andimprovement of radio- and chemotherapy sensibility after Ad administration(Arafat et al., 2000; Tsuruta et al., 2001).